PCM
Parsons Capital Management Portfolio holdings
AUM
$1.63B
This Quarter Return
+3.38%
1 Year Return
+18.89%
3 Year Return
+73.04%
5 Year Return
+126.31%
10 Year Return
+304.74%
AUM
$735M
AUM Growth
+$735M
(+0.58%)
Cap. Flow
-$15.4M
Cap. Flow
% of AUM
-2.09%
Top 10 Holdings %
Top 10 Hldgs %
29.34%
Holding
337
New
11
Increased
111
Reduced
149
Closed
18
Top Buys
Top Sells
| 1 |
Berkshire Hathaway Class A
BRK.A
|
$12.8M |
| 2 |
Eaton Vance Tax-Managed Diversified Equity Income Fund
ETY
|
$2.43M |
| 3 |
JPM.WS
JPMorgan Chase
JPM.WS
|
$1.72M |
| 4 |
3M
MMM
|
$1.72M |
| 5 |
Dollar Tree
DLTR
|
$825K |
Sector Composition
| 1 | Industrials | 14.93% |
| 2 | Healthcare | 14.57% |
| 3 | Technology | 13.26% |
| 4 | Financials | 9.86% |
| 5 | Energy | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Danaher
DHR
$143B
| $6.13M | 0.83% |
60,717
-1,079
| -2% | -$109K |
|
27
Merck
MRK
$210B
| $5.99M | 0.82% |
104,028
-1,499
| -1% | -$86.4K |
|
28
iShares Core S&P 500 ETF
IVV
$660B
| $5.95M | 0.81% |
28,285
+1,428
| +5% | +$301K |
|
29
MiMedx Group
MDXG
$1.05B
| $5.8M | 0.79% |
727,250
+2,550
| +0.4% | +$20.3K |
|
30
Thermo Fisher Scientific
TMO
$183B
| $5.66M | 0.77% |
38,299
-65
| -0.2% | -$9.6K |
|
31
Alphabet (Google) Class A
GOOGL
$2.79T
| $5.59M | 0.76% |
7,939
+371
| +5% | +$261K |
|
32
Blackrock
BLK
$170B
| $5.3M | 0.72% |
15,479
+120
| +0.8% | +$41.1K |
|
33
Mondelez International
MDLZ
$79.3B
| $5.28M | 0.72% |
115,971
-2,465
| -2% | -$112K |
|
34
Vanguard Short-Term Corporate Bond ETF
VCSH
$35.3B
| $5.26M | 0.72% |
65,055
-298
| -0.5% | -$24.1K |
|
35
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$54.2B
| $5.24M | 0.71% |
58,551
+929
| +2% | +$83.1K |
|
36
AT&T
T
$208B
| $5.2M | 0.71% |
120,414
+2,826
| +2% | +$122K |
|
|
CELG
37
DELISTED
Celgene Corp
CELG
| $5.02M | 0.68% |
50,915
+1,475
| +3% | +$145K |
|
38
Abbott
ABT
$230B
| $5.02M | 0.68% |
127,642
+53
| +0% | +$2.08K |
|
39
AbbVie
ABBV
$374B
| $4.96M | 0.67% |
80,029
-1,855
| -2% | -$115K |
|
40
Bristol-Myers Squibb
BMY
$96.7B
| $4.73M | 0.64% |
64,302
-2,945
| -4% | -$217K |
|
41
ConocoPhillips
COP
$118B
| $4.55M | 0.62% |
104,271
+5,596
| +6% | +$244K |
|
42
RTX Corp
RTX
$212B
| $4.43M | 0.6% |
43,226
-350
| -0.8% | -$35.9K |
|
43
Nike
NKE
$110B
| $4.37M | 0.59% |
79,076
-1,855
| -2% | -$102K |
|
44
iShares Preferred and Income Securities ETF
PFF
$14.4B
| $4.09M | 0.56% |
102,397
-4,719
| -4% | -$188K |
|
45
Vanguard Mid-Cap ETF
VO
$86.8B
| $3.74M | 0.51% |
30,271
+730
| +2% | +$90.2K |
|
46
Wells Fargo
WFC
$258B
| $3.73M | 0.51% |
78,699
+1,199
| +2% | +$56.8K |
|
47
Medtronic
MDT
$118B
| $3.71M | 0.5% |
42,714
-415
| -1% | -$36K |
|
48
Vanguard FTSE Developed Markets ETF
VEA
$169B
| $3.45M | 0.47% |
97,452
-20,930
| -18% | -$740K |
|
49
iShares Morningstar Mid-Cap ETF
IMCB
$1.17B
| $3.39M | 0.46% |
22,725
-460
| -2% | -$68.7K |
|
50
Vanguard FTSE Emerging Markets ETF
VWO
$96.5B
| $3.34M | 0.45% |
94,904
+15,120
| +19% | +$533K |
|